In Silico Ligand-Receptor Docking of Potentially Selective Butyrylcholinesterase Inhibitors Structurally Related to the Marine Natural Product Debromoflustramine B

Publisher： Bentham Science Publishers

E-ISSN： 1875-6638|6|3|141-143

ISSN： 1573-4064

Source： Medicinal Chemistry, Vol.6, Iss.3, 2010-05, pp. : 141-143

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Docking of Opiates and Opioid Peptides, a Tool for the Design of Selective Agonists and Antagonists, and for the Investigation of Atypical Ligand-Receptor Interactions

By  

Current Medicinal Chemistry, Vol. 19, Iss. 11, 2012-04 ,pp. : 1587-1601

Bentham Science Publishers

Access to resources Recommend Favorite

Quinoxaline Derivatives: Novel and Selective Butyrylcholinesterase Inhibitors

By  

Medicinal Chemistry, Vol. 10, Iss. 7, 2014-11 ,pp. : 724-729

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Marine and Microbial Natural Product Inhibitors of Vacuolar ATPase

By  

Current Medicinal Chemistry, Vol. 10, Iss. 9, 2003-05 ,pp. : 787-796

Bentham Science Publishers

Access to resources Recommend Favorite

Screening marine natural products for selective inhibitors of key kynurenine pathway enzymes

By Feng Y.   Bowden B.F.   Kapoor V.  

Redox Report, Vol. 5, Iss. 2-3, 2000-04 ,pp. : 95-97

Maney Publishing

Access to resources Recommend Favorite

Synthesis and receptor docking studies of N-substituted indole-2-carboxylic acid esters as a search for COX-2 selective enzyme inhibitors

By Olgen S.   Akaho E.   Nebioglu D.  

European Journal of Medicinal Chemistry, Vol. 36, Iss. 9, 2001-09 ,pp. : 747-770

Elsevier

Access to resources Recommend Favorite